Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Global Pharmaceutical Continuous Manufacturing
... adoption in specific areas such as small molecule oral solid dosage forms and large molecules, the market has consistently demonstrated robust year-on-year growth. Projections indicate that the global pharmaceutical continuous manufacturing market will experience a ... Read More
-
2024 Global Forecast for Biosimilar Contract Manufacturing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Biologics Contract Development Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Biosimilar Monoclonal Antibodies Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
PEGylated Proteins Market
... the competitive environment for PEGylated proteins, including coverage of the pipeline activities adopted by players in this market, and it includes market projections for 2028. Also included are company profiles of key players featuring detailed ... Read More
-
Global Erythropoietin Drugs Databank Market Report
... 2029. Cancer segment is expected to be the highest contributor to this market, with $3,381.2 Million in 2020, and is anticipated to reach $6,689.5 Million by 2029, registering a CAGR of 7.92%. Renal Diseases segment ... Read More
-
Global Membrane Bioreactor Systems Databank Market Report
... 2021 to 2029. Flat Sheet segment is expected to be the highest contributor to this market, with $4,081.1 Million in 2020, and is anticipated to reach $7,726.6 Million by 2029, registering a CAGR of 7.40%. ... Read More
-
Global Bioreactors Databank Market Report
... from 2023 to 2031. Single-use segment is expected to be the highest contributor to this market, with $12,231.2 Million in 2022, and is anticipated to reach $20,945.6 Million by 2031, registering a CAGR of 6.20%. Read More
-
Global Wound Care Biologics Databank Market Report
... 2023 to 2031. Ulcers segment is expected to be the highest contributor to this market, with $730.2 Million in 2022, and is anticipated to reach $1,212.3 Million by 2031, registering a CAGR of 5.84%. Surgical ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
... Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, ... Read More
-
Automation in Biopharma Industry Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Machine Flexibility and Labour Shortages ... Read More
-
Healthcare IT Outsourcing Market Size, Trends, Analysis, and Outlook By Type (Payers, Providers), By End-User (Healthcare Provider System, Biopharmaceutical Industry, Clinical Research Organization, Others), by Country, Segment, and Companies, 2024-2032
... market size is poised to register 16.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Healthcare IT Outsourcing market across By Type ... Read More
-
Biologics CDMO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 12.78% during the forecast period (2024-2029). With an increasing number of companies within the pharmaceutical sector considering outsourcing services, the demand for services from contract manufacturing and ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi & Molecular Therapy, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032
... Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032 The global Biopharmaceutical Contract Manufacturing market size is poised to register 8.3% growth from 2024 to 2032, presenting significant ... Read More
-
Continuous Bioprocessing Market Size, Trends, Analysis, and Outlook By Product (Chromatography Systems and Consumables, Filtration Systems and Devices, Bioreactors, Cell Culture Media, Cell Lines, Buffers and Reagents, Others), By Scale of Operation (Commercial Operations, Clinical Operations), By Process (Downstream Bioprocess, Upstream Bioprocess), By Application (Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, Others), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), by Country, Segment, and Companies, 2024-2032
... Operations), By Process (Downstream Bioprocess, Upstream Bioprocess), By Application (Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, Others), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), by Country, Segment, and Companies, ... Read More
-
Bioprocessing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
... (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & ... Read More
-
Cell Culture Media Market – By Product Type (Serum-free Media {CHO, HEK 293, BHK}, Stem-cell Culture Media), Application (Biopharmaceutical Production {Vaccine, Monoclonal Antibodies}, Diagnostics), End-user – Global Forecast (2024 – 2032)
... size is projected to expand at 12.8% CAGR from 2024 to 2032. The rising demand for biopharmaceuticals, such as vaccines and monoclonal antibodies is necessitating the use of high-quality cell culture media in production processes. ... Read More
-
Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2024-2032
... global glioblastoma multiforme treatment market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. ... Read More
-
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2024-2032
... pharmaceutical contract packaging market size reached US$ 21.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The ... Read More
-
North America Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Country 2024-2032
... 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The increasing cellular therapies and biomarker testing, escalating need to reduce ... Read More
-
Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global oncology biosimilars market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.3 Billion ... Read More
-
Europe Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The Europe microcarriers market is expected to grow from US$ 417.19 million in ... Read More
-
Middle East & Africa Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The Middle East & Africa microcarriers market is expected to ... Read More
-
Asia Pacific Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The Asia Pacific microcarriers market is expected to grow from US$ 366.14 ... Read More
-
South & Central America Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The South & Central America microcarriers market is expected to ... Read More
Research Assistance
